Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 9489931)

Published in Psychopharmacology (Berl) on January 01, 1998

Authors

H V Curran1, P Pooviboonsuk, J A Dalton, M H Lader

Author Affiliations

1: Clinical Health Psychology, University College London, UK.

Articles citing this

Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci U S A (2001) 1.74

How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology (2010) 1.06

Using EEG to monitor anesthesia drug effects during surgery. J Clin Monit Comput (2006) 0.98

Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine. Anesthesiology (2004) 0.97

A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal. Psychopharmacology (Berl) (2007) 0.92

Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance. Br J Pharmacol (2009) 0.86

Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans. Psychopharmacology (Berl) (2011) 0.84

Cholinergic modulation of auditory processing, sensory gating and novelty detection in human participants. Psychopharmacology (Berl) (2012) 0.84

Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice. J Pharmacol Exp Ther (2009) 0.84

Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust. Psychopharmacology (Berl) (2006) 0.83

Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study. Menopause (2010) 0.83

What do phasic cholinergic signals do? Neurobiol Learn Mem (2016) 0.80

Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine. Psychopharmacology (Berl) (2006) 0.80

Inhibition of MDMA-induced increase in cortisol does not prevent acute impairment of verbal memory. Br J Pharmacol (2013) 0.79

Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests. Psychopharmacology (Berl) (2004) 0.78

Human genome-guided identification of memory-modulating drugs. Proc Natl Acad Sci U S A (2013) 0.78

Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram. Psychopharmacology (Berl) (2014) 0.78

Human models as tools in the development of psychotropic drugs. Dialogues Clin Neurosci (2002) 0.78

Dose effects of triazolam on brain activity during episodic memory encoding: a PET study. Psychopharmacology (Berl) (2006) 0.77

Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine. Front Neurol (2016) 0.75

Neurophysiological pharmacodynamic measures of groups and individuals extended from simple cognitive tasks to more "lifelike" activities. Clin Neurophysiol (2012) 0.75

Objective markers of drug effects on brain function from recordings of scalp potential in healthy volunteers. Dialogues Clin Neurosci (2002) 0.75

Articles by these authors

(truncated to the top 100)

Withdrawal from long-term benzodiazepine treatment. Br Med J (Clin Res Ed) (1981) 3.83

Residual effects of hypnotics. Psychopharmacologia (1972) 3.43

The residual effects of flurazepam. Psychopharmacologia (1973) 2.93

Residual effects of flunitrazepam. Br J Clin Pharmacol (1975) 2.56

Response to propranolol and diazepam in somatic and psychic anxiety. Br Med J (1974) 2.23

Clinical management of benzodiazepine dependence. Br Med J (Clin Res Ed) (1985) 1.68

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). Acta Psychiatr Scand (2010) 1.67

Benzodiazepine dependence. Br J Addict (1981) 1.50

Central and peripheral effects of propranolol and sotalol in normal human subjects. Br J Pharmacol (1972) 1.48

Computed axial brain tomography in long-term benzodiazepine users. Psychol Med (1984) 1.46

Physiological and psychological measures in anxious patients. Psychol Med (1974) 1.41

Plasma concentrations of benzodiazepines. Br J Clin Pharmacol (1977) 1.41

Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther (1973) 1.36

Comparative trial of L-tryptophan and amitriptyline in depressive illness. Psychol Med (1976) 1.32

Sedative effects on physiological and psychological measures in anxious patients. Psychol Med (1974) 1.25

The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol (1975) 1.23

Palmar skin conductance measures in anxiety and phobic states. J Psychosom Res (1967) 1.21

Effects of beta adrenergic blockade with sotalol in chronic anxiety. Clin Pharmacol Ther (1973) 1.18

Drug-induced extrapyramidal syndromes. J R Coll Physicians Lond (1970) 1.12

Withdrawal reaction from clobazam. Br Med J (Clin Res Ed) (1981) 1.08

Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol (1989) 1.08

The inheritance of neurotic traits: a twin study of the Middlesex Hospital Questionnaire. Br J Psychiatry (1971) 1.08

A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Br Med J (1976) 1.06

Hangover effect of hypnotics in man. Nature (1971) 1.06

Electromyographic studies of tremor using an averaging computer. Electroencephalogr Clin Neurophysiol (1969) 1.06

Benzodiazepine derivatives--side effects and dangers. Biol Psychiatry (1981) 1.02

Bodily reactions to people and events in schizophrenics. Arch Gen Psychiatry (1979) 1.01

Comparative effects of diazepam and buspirone on subjective feelings, psychological tests and the EEG. Int Pharmacopsychiatry (1981) 1.00

Psychometric performance during withdrawal from long-term benzodiazepine treatment. Psychopharmacology (Berl) (1983) 0.99

Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor. Psychopharmacologia (1970) 0.99

Neuroleptics and abnormal movements. Br Med J (Clin Res Ed) (1982) 0.96

The effect of adrenaline on human platelet MAO activity. Psychopharmacologia (1975) 0.96

Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. Br J Psychiatry (1982) 0.96

Is nicotine important to tobacco smoking? Clin Pharmacol Ther (1977) 0.96

The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95

Comparative psychotropic effects of metoclopramide and prochlorperazine in normal subjects. J Clin Pharmacol (1975) 0.95

A controlled comparison of fluoxetine and amitriptyline in depressed out-patients. Br J Psychiatry (1987) 0.92

Acute and chronic effects of lithium chloride on physiological and psychological measures in normals. Psychopharmacology (Berl) (1978) 0.92

Clinical comparison of anxiolytic drug therapy. Psychol Med (1974) 0.91

An evaluation of forearm blood flow as a psychophysiological measure. Psychophysiology (1971) 0.90

Unesterified fatty acids and the binding of tryptophan in human plasma. Clin Sci Mol Med (1974) 0.89

Irreversible lithium neurotoxicity: an overview. Clin Neuropharmacol (1997) 0.88

Nurses' perceptions of their pain assessment skills, pain management practices, and attitudes toward pain. Oncol Nurs Forum (1989) 0.88

Proceedings: Clinical pharmacology of chlorpromazine. Br J Pharmacol (1972) 0.87

Physiological measures in agitated and retarded depressed patients. J Psychiatr Res (1969) 0.85

Controlled trial of trimipramine, monoamine oxidase inhibitors, and combined treatment in depressed outpatients. Br Med J (1979) 0.84

Diazepam and N-desmethyldiazepam concentrations in saliva, plasma and CSF. Br J Clin Pharmacol (1980) 0.83

Effect of nitrous oxide on the auditory evoked response in man. Nature (1968) 0.82

A twin study of the genetic influences on the electroencephalogram. J Med Genet (1972) 0.82

Physiological and psychological effects of clorazepate in man. Br J Clin Pharmacol (1980) 0.82

A physiological model of phobic anxiety and desensitization. Behav Res Ther (1968) 0.81

The EEG's of chronic schizophrenic patients in hospital and in the community. Electroencephalogr Clin Neurophysiol (1978) 0.81

The knowledge and attitudes of experience oncology nurses regarding the management of cancer-related pain. Oncol Nurs Forum (1996) 0.81

Tremor in acute and chronic anxiety. Arch Gen Psychiatry (1974) 0.80

Electrodermal and heart-rate measurements in chronic and partially remitted schizophrenic patients. Acta Psychiatr Scand (1978) 0.78

Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. Eur Neuropsychopharmacol (2010) 0.78

Physiological and psychological effects of ±-propranolol, +-propranolol and diazepam in induced anxiety. Br J Clin Pharmacol (1974) 0.78

Management of benzodiazepine dependence--update 1986. Br J Addict (1986) 0.78

Aspects of psychopharmacology. Clinical pharmacology and psychiatry. Proc R Soc Med (1967) 0.77

Pain relief for cancer patients. Cancer Nurs (1988) 0.77

A controlled comparison of flupenthixol decanoate injections and oral amitriptyline in depressed out-patients. Br J Psychiatry (1982) 0.77

The effects of nitrous oxide on the auditory evoked response in a reaction time task. Psychopharmacologia (1971) 0.77

Encoding, remembering and awareness in lorazepam-induced amnesia. Psychopharmacology (Berl) (1995) 0.77

Effects of adrenaline injection on human plasma tryptophan and non-esterified fatty acids. Clin Sci Mol Med (1977) 0.77

Electrodermal activity in the affective disorders and schizophrenia. Psychol Med (1981) 0.76

The effects of alprazolam alone and combined with alcohol on central integrative activity. Eur J Clin Pharmacol (1992) 0.76

Quality of life and productivity in nurses reporting migraine. Headache (1998) 0.76

Comparative bioassay of chlordiazepoxide and amylobarbitone sodium therapies in patients with anxiety states using physiological and clinical measures. J Neurol Neurosurg Psychiatry (1965) 0.76

Pharmacology of chlorpromazine: clinical studies. Br J Pharmacol (1971) 0.75

The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function. J Psychopharmacol (1995) 0.75

The clinical actions of major tranquillizers. Proc R Soc Med (1977) 0.75

The effects on memory of pipequaline, alone or in combination with diazepam. Psychopharmacology (Berl) (1988) 0.75

Hangover effects of hypnotics in man. Br J Pharmacol (1971) 0.75

Proceedings: Residual effects of a new benzodiazepine: flurazepam. Br J Pharmacol (1972) 0.75

The effects of alcohol on psychological functions in normal volunteers after 8 days' treatment with pipequaline (PK 8165), diazepam or placebo. Eur J Clin Pharmacol (1989) 0.75

Physiological response to propranolol and diazepam in chronic anxiety. Br J Clin Pharmacol (1974) 0.75

Psychological impairment and low-dose benzodiazepine treatment. Br Med J (Clin Res Ed) (1982) 0.75

A neuroendocrine approach to benzodiazepine tolerance and dependence. Br J Clin Pharmacol (1981) 0.75

Soma and psyche. Br Med J (Clin Res Ed) (1984) 0.75

Treatment of affective disorders. Br J Clin Pharmacol (1985) 0.75

The effect of nitrous oxide on reaction time and cerebral evoked potential. Br J Pharmacol (1970) 0.75

The beginning of clinical pastoral care in the Philippines. J Pastoral Care (1983) 0.75

An electromyographic study of depressed patients. J Psychosom Res (1971) 0.75

Rational use of anxiolytic drugs. Ration Drug Ther (1987) 0.75

Monoamine metabolism during chronic benzodiazepine treatment and withdrawal. Biol Psychiatry (1983) 0.75

Failure of clonidine treatment in benzodiazepine withdrawal. J Psychopharmacol (1990) 0.75

Comparison of methods of relaxation using physiological measures. Behav Res Ther (1970) 0.75

The unit of quantification of the G.S.R. J Psychosom Res (1970) 0.75

Determination of excitability in human proprioceptive reflexes: analysis and characteristics of EMG thresholds of postural muscle. Brain Res (1985) 0.75

The nurse's ethical obligation to relieve pain: actualizing the moral mandate. J Nurs Law (2001) 0.75

Physiological measures in psychiatry. Sci Basis Med Annu Rev (1971) 0.75

Electromyographic studies of tension. J Psychosom Res (1971) 0.75

Nurses and smoking: role modeling and counseling behaviors. Oncol Nurs Forum (1986) 0.75

Central benzodiazepine receptor imaging and quantitation with single photon emission computerised tomography: SPECT. J Psychopharmacol (1995) 0.75

A comparison of the knowledge and attitudes about smoking among nurses who never smoked, those who have successfully stopped smoking and those who currently smoke. Int J Nurs Stud (1983) 0.75

Palmar skin conductance measures as predictors of response to desensitization. J Psychosom Res (1967) 0.75

A study of buspirone co-presented with antihistamines in 68 anxious ambulatory patients. J Clin Psychopharmacol (1988) 0.75

A case of resistant schizophrenia. Br J Psychiatry (1986) 0.75

Physical and physiological aspects of anxiety and depression. Br J Clin Pract (1970) 0.75

Insomnia and short-acting benzodiazepine hypnotics. J Clin Psychiatry (1983) 0.75